Cargando…
Assessing the performance of different outcomes for tumor growth studies with animal models
The consistency of reporting results for patient‐derived xenograft (PDX) studies is an area of concern. The PDX method commonly starts by implanting a derivative of a human tumor into a mouse, then comparing the tumor growth under different treatment conditions. Currently, a wide array of statistica...
Autores principales: | Patten, Luke W., Blatchford, Patrick, Strand, Matthew, Kaizer, Alexander M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240739/ https://www.ncbi.nlm.nih.gov/pubmed/35699330 http://dx.doi.org/10.1002/ame2.12250 |
Ejemplares similares
-
Implementation and 1-year follow-up of the cardiovascular ICU standardised handover
por: Lupei, Monica, et al.
Publicado: (2021) -
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma
por: Thieblemont, Catherine, et al.
Publicado: (2022) -
Simvastatin Attenuated Tumor Growth in Different Pancreatic Tumor Animal Models
por: Chen, Chao-Yi, et al.
Publicado: (2022) -
Inhibitory Effects of Anti-VEGF Antibody on the Growth and Angiogenesis of Estrogen-induced Pituitary Prolactinoma in Fischer 344 Rats: Animal Model of VEGF-targeted Therapy for Human Endocrine Tumors
por: Miyajima, Katsuhiro, et al.
Publicado: (2010) -
Era of the 4D animal model
por: Zhang, Lihong, et al.
Publicado: (2023)